Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Genome Engineering Market Size, Share, and Trends - Global Forecast 2026-2032 | CRISPR Commercialization and AI Innovation Propel 16.17% CAGR Toward USD 24.24 Billion

globenewswire.com
AGNC AgBiome, Inc. is listed as a company in the genome engineering market, which is projected to grow significantly. The article does not provide specific sentiment for this company. A Agilent Technologies, Inc. is mentioned as a player in the genome engineering market, which is experiencing substantial growth driven by AI and CRISPR commercialization. No specific sentiment is detailed for Agilent. BEAM Beam Therapeutics is identified as a company in the genome engineering space, benefiting from advancements like base editing and prime editing. The article does not offer specific sentiment. BIO Bio-Rad Laboratories, Inc. is listed among companies in the genome engineering market, which is poised for significant growth. The article does not provide specific sentiment for Bio-Rad. CTVA Corteva Agriscience is listed as a company within the genome engineering market, which is experiencing strong growth. The article does not offer specific sentiment for Corteva. CRSP CRISPR Therapeutics AG is a key player in the genome engineering market, with CRISPR-Cas systems being a major technology driving growth. The approval of CRISPR-based therapies indicates strong positive momentum. DHR Danaher Corporation is listed as a company in the genome engineering market, which is projected to grow significantly. The article does not provide specific sentiment for Danaher. REGN Intellia Therapeutics, Inc. is a company in the genome engineering market, benefiting from advancements in CRISPR technology and its application in therapeutics. The overall market growth is positive. QGEN QIAGEN N.V. is mentioned as a company within the genome engineering market, which is expected to grow substantially. The article does not provide specific sentiment for QIAGEN. TMO Thermo Fisher Scientific Inc. is mentioned as a company in the genome engineering market, which is projected for strong growth. The article does not offer specific sentiment for Thermo Fisher. TWST Twist Bioscience is listed as a company in the genome engineering market, which is expected to grow significantly. The article does not provide specific sentiment for Twist Bioscience.

Genome Engineering Market Size, Share, and Trends - Global Forecast 2026-2032 | CRISPR Commercialization and AI Innovation Propel 16.17% CAGR Toward USD 24.24 Billion Dublin, Nov. 19, 2026 (GLOBE NEWSWIRE) -- "Genome Engineering Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The genome engineering market research provides a comprehensive assessment of technologies, applications, competitive dynamics, and geographic opportunities shaping this rapidly expanding industry. Valued at a projected USD 9.83 billion in 2026, the market is expected to grow at a CAGR of 16.17% to reach USD 24.24 billion by 2032.

Market Overview

Genome engineering is advancing from a research-focused discipline into a commercially validated foundation for precision medicine, biomanufacturing, agriculture, and synthetic biology. Key technologies include CRISPR-Cas systems, base editing, prime editing, zinc finger nucleases, TALENs, and viral and non-viral delivery platforms.

Regulatory approvals have accelerated commercial momentum. The United Kingdom authorized the first CRISPR-based therapy in November 2023, followed by the United States in December 2023 for sickle cell disease. These milestones are increasing strategic interest across oncology, rare diseases, infectious disease research, crop development, and industrial biotechnology.

Transformative Market Shifts

The market is being reshaped by programmable nucleases, high-throughput sequencing, improved delivery systems, automation, and cloud-enabled computational biology. CRISPR-Cas9 remains widely adopted, while base and prime editing are attracting interest for their potential to achieve precise changes without double-strand DNA breaks.

Demand is shifting from standalone tools toward integrated platforms encompassing guide RNA design, off-target analysis, cell engineering, analytical validation, GMP readiness, and regulatory documentation. This analysis supports strategic planning by identifying the capabilities most likely to influence platform selection, partnerships, and long-term competitive positioning.

Artificial Intelligence in Genome Engineering

Artificial intelligence is accelerating target discovery, guide RNA selection, protein engineering, enzyme development, delivery-vector optimization, and off-target risk prediction. Models trained on genomic, transcriptomic, proteomic, and clinical data can reduce experimental cycles and improve edit prioritization.

Resources such as the AlphaFold Protein Structure Database demonstrate the value of broad access to predicted protein structures. As AI adoption expands, transparent validation, responsible data governance, and reproducibility will become increasingly important.

Regional and Economic Group Insights

Country-level comparisons offer practical guidance for evaluating market-entry options, regional partnerships, regulatory exposure, and investment priorities.

Strategic Priorities for Industry Leaders

These insights enable decision-makers to identify high-potential applications, mitigate development risks, and prioritize investments aligned with clinical and commercial readiness.

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Genome Engineering Market, by Offering

7.1. Introduction

7.2. Instruments

7.2.1. Electroporation Systems

7.2.2. Microinjection Systems

7.3. Reagents & Consumables

7.3.1. Delivery Reagents

7.3.2. Kits & Enzymes

7.4. Software

7.4.1. Data Analysis

7.4.2. Design

7.5. Services

7.5.1. Screening

7.5.2. Assay Development

8. Genome Engineering Market, by Technology

8.1. Introduction

8.2. CRISPR Systems

8.2.1. CRISPR/Cas12

8.2.2. CRISPR/Cas9

8.3. Meganucleases

8.4. Transcription Control

9. Genome Engineering Market, by Delivery Method

9.1. Introduction

9.2. Ex-vivo

9.3. In-vivo

10. Genome Engineering Market, by Application

10.1. Introduction

10.2. Genetic Engineering

10.3. Clinical Therapeutics

10.4. Research & Discovery

11. Genome Engineering Market, by End User

11.1. Introduction

11.2. Academic & Research Institutes

11.3. Contract Research Organizations

11.4. Pharmaceutical & Biotechnology Companies

12. Genome Engineering Market, by Region

12.1. Introduction

12.2. Asia-Pacific

12.3. North America

12.4. Latin America

12.5. Europe

12.6. Middle East

12.7. Africa

13. Genome Engineering Market, by Group

13.1. Introduction

13.2. ASEAN

13.3. GCC

13.4. European Union

13.5. BRICS

13.6. G7

13.7. NATO

14. Genome Engineering Market, by Country

14.1. Introduction

14.2. United States

14.3. Canada

14.4. Mexico

14.5. Brazil

14.6. United Kingdom

14.7. Germany

14.8. France

14.9. Russia

14.10. Italy

14.11. Spain

14.12. China

14.13. India

14.14. Japan

14.15. Australia

14.16. South Korea

15. Competitive Landscape

15.1. Market Share Analysis, 2025

15.2. Market Concentration Analysis, 2025

15.2.1. Concentration Ratio (CR)

15.2.2. Herfindahl Hirschman Index (HHI)

15.3. Recent Developments & Impact Analysis, 2025

15.4. Product Portfolio Analysis, 2025

15.5. Benchmarking Analysis, 2025

16. Company Profiles

16.1. AgBiome, Inc.

16.2. Agilent Technologies, Inc.

16.3. BASF SE

16.4. Bayer AG

16.5. Beam Therapeutics

16.6. Bio-Rad Laboratories, Inc.

16.7. Charles River Laboratories Inc.

16.8. Cibus Inc.

16.9. Clinisys, Inc.

16.10. Corteva Agriscience

16.11. Creative Biogene

16.12. CRISPR Therapeutics AG

16.13. Danaher Corporation

16.14. GenScript Biotech Corporation

16.15. Groupe Limagrain Holding

16.16. Intellia Therapeutics, Inc.

16.17. Lonza Group AG

16.18. Merck KGaA

16.19. New England Biolabs

16.20. QIAGEN N.V.

16.21. Revvity Inc.

16.22. Synthego Holdings LLC

16.23. Takara Bio Inc.

16.24. Thermo Fisher Scientific Inc.

16.25. Twist Bioscience

17. Key Experts

List of Figures [21]

List of Tables [369]

For more information about this report visit https://www.researchandmarkets.com/r/q4sr7m

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.